4
Changes in Ownership
INSMED Inc Filed Acc 0001628280-24-023613
Chief Commercial Officer sold 5,088 shares at $25.47 ($129,591)
- Chief Commercial Officer acquired 14,518 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Wise John Drayton · Chief Commercial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-05-13 | Grant or award : show line 1 in the form | +14,518 | 128,347 | D | ||
| 2024-05-14 | Sale : show line 2 in the form | −5,088 | $25.47 | $129,591 | 123,259 | D |
| Open-market sales · 5,088 sh · avg $25.47 · $129,591 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-05-13 | Grant or award : show line 3 in the form Stock Option (right to buy) | +71,160 | 71,160 | D |
Loading xslF345X05/wk-form4_1715805527.xml…